Abstract
Altered expression of mucin gene products has been described in many epithelial cancers including colorectal cancer. However, mucins are heavily O-glycosylated making the study of apomucin expression difficult. In this study, we describe a novel method of chemical deglycosylation of mucin gene products on paraffin embedded formalin-fixed tissue sections. In the normal and cancerous colorectum, our results suggest that alkali-catalyzed β-elimination of periodate oxidized glycan method of chemical deglycosylation modifies the structure of carbohydrates sensitive to mild periodate oxidation resulting in less steric hindrance and selectively removes Tn and sialyl-Tn structures, partially exposing the underlying apomucin epitopes. Using this method, we have demonstrated that the MUC1 tandem repeat epitope recognized by MAb 139H2 is masked predominantly due to steric hindrance by carbohydrate structures whereas the MUC2 tandem repeat epitope recognized by MAb CCP58 and pAb MRP and the MUC3 tandem repeat epitope recognized by pAb M3P are masked by the presence of carbohydrate side chains O-linked to Ser/Thr residues within the epitope. Considerable differences in the level and pattern of expression of the epitopes in the tandem repeat region of apomucins of MUC1, MUC2, and MUC3 were observed between normal and cancerous colorectal cancer tissues. We conclude that this novel chemical deglycosylation method that causes selective cleavage of distinct glycans will be useful in unmasking various mucin gene products and glycoproteins containing similar O-glycosidic linkages in the tissue sections of formalin-fixed paraffin embedded normal and pathological tissues.
Similar content being viewed by others
References
Kim YS, Gum JR, Brockhausen I, Glycoconjugates J 13, 693–707 (1996).
Lesuffeur T, Zweibaum A, Real FX, Critical Reviews in Oncology/Hematology 17, 153–80 (1994).
Berman E, Biochemistry 23, 3754–9 (1984).
Chang SK, Dohrman AF, Basbaum CB, Ho SB, Tsuda T, Toribara NW, Gum Jr, Kim YS, Gastroenterology 107, 28–36 (1994).
Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS, Cancer Res 53, 641–51 (1993).
Gold D, Miller F, Nature 255, 85–7 (1975).
Podolsky DK, Fournier DA, Lynch KE, J Clin Invest 77, 1251–62 (1986).
Podolsky DK, Fournier DA, Lynch KE, J Clin Invest 77, 1263–71 (1986).
Gambús G, de Bolós C, Andreu D, Francí C, Egea G, Real FX, Gastroenterology 104, 93–102 (1993).
Pemberton L, Taylor-Papadimitrou J, Gendler SJ, Biochem Biophys Res Commun 185, 167–75 (1992).
Bara J, Decaens C, Loridon-Rosa B, Oriol R, J Immunol Methods 149, 105–13 (1992).
Cao Y, Blohm D, Ghadimi BM, Stosiek P, Xing P-X, Karsten U, J Histochem Cytochem 45, 1547–57 (1997).
Bobbitt JM, Adv Carbohydrate Chem Biochem 11, 1 (1956).
Woodward MP, Young WW, Bloodgood RA, J Immunol Methods 78, 143–53 (1985).
Gerken TA, Gupta R, Jentoft N, Biochemistry 3l, 639–48 (1992).
Gerken TA, Owens CL, Pasumarthy M, J Biol Chem 273, 26580–8 (1998).
Ogata S, Uehara H, Chen A, Itzkowitz SH, Cancer Res 52, 5971–8 (1992).
Ogata S, Ho I, Chen A, Dubois D, Maklansky J, Singhal A, Hakamori S, Itzkowitz SH, Cancer Res 55, 1869–74 (1995).
Tollefsen SE, Kornfeld R, J Biol Chem 258, 5172–6 (1983).
Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, Iijima H, Hakomori S, Cancer Res 48, 2214–20 (1998).
Stroud MR, Handa K, Ito K, Salyan ME, Fang H, Levery SB, Hakomori S, Biochem Biophys Res Commun 209, 777–87 (1995).
Veerman ECI, Bolscher JGM, Appelmelk BJ, Bloemena E, van den Berg TK, Amerongen NAV, Glycobiology 7, 37–43 (1997).
Ligtenberg MJL, Vos HL, Gennissen AMC, Hilkens J, J Biol Chem 265, 5573–8 (1990).
Xing P-X, Prenzoska J, Layton GT, Devine PT, McKenzie IFC, J Natl Cancer Inst 84, 699–703 (1992).
Gum JR, Byrd JC, Hicks JW, Toribara NW, Lamport DTA, Kim YS, J Biol Chem 264, 6480–7 (1989).
Gum JR, Hicks JW, Swallow DM, Lagace RE, Byrd JC, Lamport DTA, Siddiki B, Kim YS, Biochem Biophys Res Commun 171, 407–15 (1990).
Ho JJL, Siddiki B, Kim YS, Cancer Res 55, 3659–63 (1995).
Hotchkiss RD, Arch Biochem 16, 131–41 (1948).
Pancino G, Charpin C, Osinaga E, Betaille B, LeRoy M, Calvo F, Roseto A, Cancer Res 50, 7333–42 (1990).
Kim YS, Gastroenterology Intl 2, 101–6 (1989).
Kim YS, Cancer Biology 1, 189–97 (1990).
Podolsky DK, J Biol Chem 260, 8262–8271 (1985).
Podolsky DK, J Biol Chem 260, 15510–5 (1985).
Karsten U, Diotel C, Klick G, Paulsen H, Goletz S, Muller S, Hanisch F-G, Cancer Res 58, 2541–9 (1998).
Springer GF, Ghazizadeh M, Desai PR, Tegtmeyer H, Cancer Detect Prevent 19, 173–82 (1995).
Takahashi HK, Metoki R, Hakomori S, Cancer Res 48, 4361–7 (1988).
Siddiki BB, Huang J, Ho JJL, Byrd JC, Lau E, Yuan M, Kim YS, Int J Cancer 54, 467–74 (1993).
Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS, Cancer Res 49, 197–204 (1989).
Yang J-M, Byrd JC, Siddiki BB, Chung Y-S, Okuno M, Sowa M, Kim YS, Matta KL, Brockhausen I, Glycobiology 4, 873–84 (1994).
Vavasseur F, Yang J-M, Dole K, Pausen H, Brockhausen I, Glycobiology 5, 351–7 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hong, J.C., Kim, Y.S. Alkali-catalyzed β-elimination of periodate-oxidized glycans: A novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections. Glycoconj J 17, 691–703 (2000). https://doi.org/10.1023/A:1011014404707
Issue Date:
DOI: https://doi.org/10.1023/A:1011014404707